Investigaciones sobre la toxicidad de los bloqueadores solares químicos

• 
  DiNardo JC, D. C. (2018). Dermatological and evironmental toxicological impact of the suncreen ingredient oxybenzone/benzophenone-3. J Cosmet Dermatol, 17, 15-19.
  
• 
  Warshaw EM, W. M., Maibach HI, et al. . (2013). Patch test reactions asso-ciated with sunscreen products and the importance of testing to anexpanded series: retrospective analysis of North American ContactDermatitis Group data, 2001 to 2010. Dermatitis, 24, 176-182.
  
• 
  Heneweer et al. (2005). “Additive estrogenic effects of mixtures of frequently used UV filters on pS2-gene transcription in MCF-7 cells.” Toxicol Appl Pharmacol 208: 170-177.
  
• 
  Ma R et al. (2003). UV filters with antagonistic action at androgenreceptors in the MDA-kb2 cell transcriptional-activation assay. Toxicol Sci, 74, 43-50.
  
• 
  Nakagawa Y, S. T. (2002). Metabolism of 2-hydroxy-4-methoxy-benzophenone in isolated rat hepatocytes and xenoestrogeniceffects of its metabolites on MCF-7 human breast cancer cells. Chem Biol Interact, 139, 115-128.
  
• 
  Schlumpf et al. In vitro and in vivo estrogenicity of UVscreens. Enivron Health Perspect, 109, 239-24 (corresponds to KRISTEN MAERKEL)